Coronavirus (COVID-19) Research Highlights

Find free access to the latest COVID-19 research papers and articles

Springer Nature is committed to supporting the global response to COVID-19 enabling fast and direct access to the latest available research, evidence, and data.

The need for continued access to research and learning has never been more important. We recognise our role in this and are working with global organisations, such as the World Health Organisation and the initiative from the White House Office of Science and Technology to make all relevant global research, and data, immediately available. We also continue to work directly with teachers, lecturers, librarians, students and institutions to support their work. See more from our CEO, Frank Vrancken Peeters.

So far we have:

  • Enabled free access to over 60,000 articles, book chapters, reference works and protocols on our platforms 
  • Published over 10,000 new COVID-19 articles and supported all researchers in making their underlying experimental data sets available for free and re-use
  • Made available, via Research Square, over 1300 COVID-19 preprint articles

Below, you will find links to key resources, free content and updated information related to COVID-19, alongside key policies and information in supporting remote access and working. Please contact our Customer Services Team if you require further support.

Free access to COVID-19 journal and book content

Remote Access: Information & resources for librarians

Remote Access: Resources for institutions and students

Remote Access: Learn about remote access for researchers

Supporting COVID-19 Research

How can AI support the research community in times of crisis?

Learn how AI was used to build a rapid prototype report to give a quick and simple overview of coronavirus research. Explore the short report which clusters COVID-19 papers published in 2020 in a meaningful way for researchers.

Research Data Support

To support the rapid and wide dissemination of research during the COVID-19 outbreak, eligible Springer Nature authors can use our Research Data Support service for COVID-19 data at 50% off the standard cost.

In Review and Preprints

Springer Nature encourages early sharing of research submitted to all our journals through preprints, and our In Review preprint service is available for many journals.


For API purposes, we have made additional content free via the SN OpenAccess API.

Access COVID-19 Research Papers & Articles Across Journals, Books & More

We have made over 19,000 pieces of research from our journals and books available for free and will continue to do so as new relevant research is published. Highlighted links can be found below, and content can also be found through keyword search on our imprint pages. If you find you are unable to access an article that you believe to be important in both understanding and addressing this emergency, please contact our customer services team.

Access more COVID-19 research on our platforms


A pioneer of open access, BMC’s journals include broad scope titles such as BMC Public Health and Virology Journal, and more specialist journals such as Globalization and Health and Conflict and Health. This collection draws together coronavirus research from across BMC.

Read more


To support research to combat the COVID-19 outbreak, Nature Research have opened a collection covering the biology of coronavirus infection, its detection, treatment and evolution, research into the epidemiology of emerging viral diseases, and coverage of current events.

Read more


In response to the COVID-19 pandemic, Springer have made corona-related research free to access. This content spans across our journals, books, protocols, conference papers, and other content types.

Read more

Featured blog posts from "The Source"See all

Providing insight and discussion for researchers on publishing in the academic world

Research in the time of a pandemic: SENTINEL- A proactive, early warning system to pre-empt future pandemics


Dr Sabeti and Dr Happi talk about building a pandemic preemption system to safeguard us from future pandemics.

The Source
23 Jul 2020
Research in the time of a pandemic: Coronavirus, Class and Mutual Aid in the UK


In this week's blog we discuss how the economic systems in place played a role into how the pandemic has developed.

The Source
16 Jul 2020
Research in the time of a pandemic: Africa Centres for Disease Control and Prevention


Read about the Centres for Disease Control and Prevention in Africa and their role during the pandemic.

The Source
09 Jul 2020
Research in the time of a pandemic: Leading the Oxford Vaccine Trial


Dr Sarah Gilbert, the lead for the Oxford Vaccine Trial for COVID-19 talks about the vaccine.

The Source
02 Jul 2020

Keep up with the latest news on COVID-19 Research

Nature Briefing

Sign up to a free daily update on COVID-19, plus a selection of the most important non-coronavirus science news


Nature provides authoritative, timely news and opinion articles on the novel coronavirus and COVID-19

Scientific American International

Scientific American’s international network of magazines now brings you the latest science news and expert analysis on the pandemic in one place

Additional Resources


AdisInsight provides profiles of drug development programs actively investigating treatments for Coronavirus and summaries of the clinical trials being conducted for those drugs.

Nano – a Nature Research Solution

Access manually extracted nanomaterial summaries in addition to thousands of freely available patents and article links on the interaction, diagnostics and therapeutic effects of nanomaterials on coronavirus.

Springer Nature Experiments

Covers over 160 well established protocols and methods for identifying & detecting coronavirus, protocols on designing the vaccine for the epidemic, understanding the ultrastructure of viruses to design new drugs.

Stay up to date

Follow us on Twitter

Here to foster information exchange with the library community

Connect on LinkedIn

Connect with us on LinkedIn and stay up to date with news and development.